Parkinson’s disease is the fastest growing neurological condition in the world and its prevalence is expected to double in the next 10–15 years. Currently approved treatments for Parkinson’s disease can only provide symptom relief; there is no “cure”.

However, there are some promising drug candidates and means of earlier diagnosis on the horizon. Thorough research to ensure the best treatment is given to the right person at the right time is absolutely essential. The goal of such research is to identify so-called disease-modifying treatments—namely, treatments that can slow, stop, and perhaps even reverse the course of disease.

This would be a gamer changer for people with Parkinson’s and the neurologists who currently have very limited means of treating them. Clinical trials and further clinical research are urgently needed to confirm the safety and benefits of the most promising candidate treatments, and to get them approved for use in patients. The cost of getting promising treatments approved for use in patients is high. But the cost to patients, their families, healthcare systems, and economies of not doing this research is much much more. We need your support to make this happen.